Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company filings document the formal record for a North American branded consumer lawn and garden company. Recent 8-K disclosures furnish operating results and financial condition, revised historical financial information reflecting Hawthorne as a discontinued operation, and the completed sale of The Hawthorne Gardening Company.
The filing record also covers capital structure and governance matters, including a senior secured credit agreement, shareholder approval of an amended and restated Long-Term Incentive Plan, forms of restricted stock unit, performance unit and stock option awards, and definitive proxy disclosures on annual meeting proposals and executive compensation.
Scotts Miracle-Gro executive Dimiter Todorov reported a disposition of company stock. On February 3, 2026, he reported the disposition of 2,254 common shares of Scotts Miracle-Gro at $63.69 per share. Following this transaction, he directly beneficially owned 19,014 common shares.
Todorov is an officer of Scotts Miracle-Gro, serving as EVP, CLO & Corporate Secretary, and filed this report as a single reporting person.
Scotts Miracle-Gro director Edith Aviles reported a share acquisition tied to equity awards. On February 3, 2026, 336 restricted stock units converted into 336 common shares at a price of $0 per share, reflecting a vesting event rather than an open-market purchase.
The filing also shows a related transaction in 336 dividend equivalent rights, which are linked to the same underlying common shares. After these transactions, Aviles directly holds 14,304 common shares and 447 dividend equivalent rights in Scotts Miracle-Gro.
Scotts Miracle-Gro executive Mark J. Scheiwer, EVP, CFO & CAO, reported an insider transaction involving company common shares. On 02/03/2026, he disposed of 612 common shares at $63.69 per share (transaction code F), a form of non-derivative disposition.
Following this transaction, Scheiwer directly beneficially owned 14,676.741 common shares. He also indirectly held an additional 493.482 common shares through a 401(k) plan, reflecting his retirement-plan stake in the company’s stock.
Scotts Miracle-Gro director Brian E. Sandoval reported the conversion of equity awards into common shares. On February 3, 2026, 336 dividend equivalent rights were exercised at $0 and delivered as 336 common shares.
Following this transaction, Sandoval directly held 18,723 common shares of Scotts Miracle-Gro and 636 dividend equivalent rights. The filing notes that restricted stock units convert into common shares on a one-for-one basis and references a prior grant of 2,553 restricted stock units with accruing dividend equivalent rights.
Scotts Miracle-Gro director Peter E. Shumlin reported an automatic conversion of 336 dividend equivalent rights into 336 common shares on February 3, 2026, at an exercise price of $0.
Following this transaction, he directly held 30,846 common shares and 692 dividend equivalent rights.
The Scotts Miracle-Gro Company reported a larger net loss as it moves to exit its Hawthorne business. For the quarter ended December 27, 2025, net sales from continuing operations were $354.4 million, down 3.3% from $366.6 million a year earlier, mainly from lower U.S. fertilizer, grass seed and controls volume partly offset by stronger soils sales and pricing.
Gross margin improved to 25.0% from 24.1% as higher pricing and lower manufacturing costs more than offset weaker volume. Loss from continuing operations narrowed to $47.8 million from $66.1 million due to better margins, lower restructuring charges, reduced SG&A and lower interest expense.
The company classified its Hawthorne business as held for sale and recorded a non‑cash pre‑tax charge of $104.8 million, driving discontinued operations loss of $77.2 million and total net loss of $125.0 million. Operating cash outflow improved to $370.4 million from $445.3 million, while total debt was $2,542.3 million and equity reflected a deficit of $500.6 million. The leverage ratio under its credit agreement was 4.03, below the 5.00 maximum covenant.
Scotts Miracle-Gro director Roberto Candelino reported acquiring additional company stock. On 01/30/2026, he acquired 3,271 Common Shares at a reported price of $0 per share, likely reflecting a no-cash equity award. After this transaction, he beneficially owned 6,614 Common Shares, held directly.
Scotts Miracle-Gro director Edith Aviles acquired 3,271 common shares on January 30, 2026 at a reported price of $0 per share. After this transaction, she directly beneficially owns 13,968 common shares of the company.
Scotts Miracle-Gro executive Christopher Hagedorn reported new equity awards and a minor share transaction. He received a stock option grant for 29,649 common shares at an exercise price of $64.22 per share, with the option expiring on 01/30/2036. The option covers 29,649 underlying common shares and is held directly.
He also reported an acquisition coded "J" of 4.179 common shares at a price of $51.93 per share. Following this transaction, he directly beneficially owned 60,115.4664 common shares of Scotts Miracle-Gro.
Scotts Miracle-Gro director Katherine Hagedorn Littlefield reported receiving 3,271 Common Shares of the company on January 30, 2026. The shares were acquired at a reported price of $0 per share, indicating a grant or similar no-cost award.
After this transaction, she directly holds 10,211 Common Shares. She is also reported as having an indirect interest in 2,774,291 Common Shares held by Hagedorn Partnership, L.P., reflecting her proportionate interest and that of certain family members in the partnership’s holdings.